Search

UKHSA VZIG 2025 Contract Modification with Grifols

UK Health Security Agency (UKHSA) has issued a contract modification notice for VZIG (Varicella-zoster immunoglobulin) 2025 with Grifols UK Limited, extending the contract through 30 April 2027. The modification authorises an increase in product volume under the existing contractual flexibility provisions. The total contract value remains at £1 excluding VAT, and the contract may be made available to UK devolved administrations, Crown Dependencies and British Overseas Territories for their immunisation programmes.